Barbara McGovern, M. D.

Barbara McGovern, M. D.

Company: Seres Therapeutics

Job title: VP Medical Affairs


ECOSPOR III data 2:55 pm

To highlight: The efficacy and safety of SER-109 in patients with recurrent CDI Efficacy of SER-109 versus placebo in patients with risk factors for recurrence The time to recurrence and the importance of rapid microbiome recovery Quality of life in patients receiving SER-109 compared to placebo Inactivation of potential pathogens in donor stool via the…Read more

day: Day 2 - Track B Evening

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.